Certificate of Analysis
GHK-Cu-2MG-6-11-26-COA
GHK-Cu-2MG-6-11-26-COA
Sale!
GHK-CU 2MG 60 CAPSULES
GHK-CU 2MG 60 CAPSULES - Image 2

122 in stock

GHK-CU 2MG 60 CAPSULES

Original price was: $198.00.Current price is: $160.00.

Certified-Pep only sells U.S.-made peptides and products.

Key Features
  • Made in the USA
  • Batch tested at a verifiable U.S. laboratory for identity, content and purity
  • Screened for endotoxins, heavy metals and sterility
  • Rigorous quality testing on every batch
  • Capsule form for precise research. Capsules are not intended for time release purposes, transport only
  • For laboratory and research use only
  • CAS: 89030-95-5
  • FORM: Encapsulated compound
  • CONTENT PER CAPSULE: 2 MG
  • PURITY: 99%+

Description

GHK-Cu 2MG 60 CAPSULES
SKU ORAL_CP_GHK_CU_2MG_60_CAP
CATEGORY Peptide Capsules
CAS 89030-95-5
PACKAGE SIZE 60 capsules per unit
FORM Encapsulated compound
MOLECULAR WEIGHT 401.91 g/mol
SEQUENCE Glycyl-L-histidyl-L-Lysine (Gly-His-Lys)
MOLECULAR FORMULA C14H22CuN6O4
ITEM ID 100069

In TNF-α/IFN-γ-stimulated HaCaT keratinocytes, a Torilis japonica extract-GHK-Cu complex (not GHK-Cu alone) was evaluated for effects on Th2-associated chemokine expression. The combination reduced transcript levels of IL-4, IL-5, IL-10, and IL-13 and decreased expression of TARC (CCL17) and CTACK (CCL27) relative to individual treatments. Radical-scavenging activity and keratinocyte migration were also assessed in this in vitro system [1].

Description

Description

GHK-Cu 2MG 60 CAPSULES
SKU ORAL_CP_GHK_CU_2MG_60_CAP
CATEGORY Peptide Capsules
CAS 89030-95-5
PACKAGE SIZE 60 capsules per unit
FORM Encapsulated compound
MOLECULAR WEIGHT 401.91 g/mol
SEQUENCE Glycyl-L-histidyl-L-Lysine (Gly-His-Lys)
MOLECULAR FORMULA C14H22CuN6O4
ITEM ID 100069

In TNF-α/IFN-γ-stimulated HaCaT keratinocytes, a Torilis japonica extract-GHK-Cu complex (not GHK-Cu alone) was evaluated for effects on Th2-associated chemokine expression. The combination reduced transcript levels of IL-4, IL-5, IL-10, and IL-13 and decreased expression of TARC (CCL17) and CTACK (CCL27) relative to individual treatments. Radical-scavenging activity and keratinocyte migration were also assessed in this in vitro system [1].

Related products